COMMUNIQUÉS West-GlobeNewswire

Surrozen to Present at Upcoming Healthcare Investor Conferences
02/09/2026
SOUTH SAN FRANCISCO, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics to harness the power of Wnt signaling [...]
Option Care Health to Participate in Upcoming Investor Conferences
02/09/2026
BANNOCKBURN, Ill., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced [...]
ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
02/09/2026
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Sept. 02, 2026 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing and commercializing treatments that [...]
SL Science Holding Limited Rings Nasdaq Bell, Capping an Active First Quarter as a Publicly Traded Company
02/09/2026
NEW YORK, Sept. 02, 2026 (GLOBE NEWSWIRE) -- SL Science Holding Limited (“SL Science” or the “Company”) (NASDAQ: SLBT), a Taiwan-headquartered biomedical company specializing in developing innovative cellular and gene [...]
AVITA Medical to Participate in Lake Street Best Ideas Growth Conference and Morgan Stanley Healthcare Conference
02/09/2026
VALENCIA, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today announced that its senior [...]
Flyte Secures International Approval to Launch Private Aviation Service Across The Bahamas and Caribbean
02/09/2026
Landmark international milestone unlocks significant new markets and broadens Flyte’s addressable aviation footprint beyond the United States New capabilities connect Flyte’s growing Florida network with high-demand [...]
Vireo Growth Announces Conference Attendance for September 2026
02/09/2026
MINNEAPOLIS, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (CSE: VREO) (OTCQX: VREOF) (“Vireo” or the “Company”), a leading vertically integrated cannabis company and agricultural markets platform, today [...]
Supernus Pharmaceuticals to Participate in September Investor Conferences
02/09/2026
ROCKVILLE, Md., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous [...]
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/09/2026
SAN FRANCISCO, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and [...]
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/09/2026
WALTHAM, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing masked immuno-oncology therapies for people living with cancer [...]
Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/09/2026
BOSTON, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA) today announced that the Company granted an aggregate of 61,365 restricted stock units (“RSUs”) and options to purchase 19,425 shares [...]
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/09/2026
NEW YORK and WALTHAM, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the [...]
NMDP Get in the Game Program Surpasses 2,000 Blood Stem Cell Donors, Celebrates Endowment to Expand Lifesaving Impact
02/09/2026
NMDP marks milestone donations through college athletics initiative and invests in the next generation of donor recruitment MINNEAPOLIS, Sept. 02, 2026 (GLOBE NEWSWIRE) -- NMDP℠ today announced a major milestone for its [...]
Society for Science Announces Top 300 for the 2026 Thermo Fisher Scientific Junior Innovators Challenge
02/09/2026
A new generation of STEM stars—tackling air quality, renewable energy, disease risk, artificial intelligence and more—has been named to the Thermo Fisher Scientific Junior Innovators Challenge Top 300 Key Takeaways: [...]
Astiva Health Achieves 4-Star Rating from Centers for Medicare & Medicaid Services for 2nd Consecutive Year
02/09/2026
ORANGE, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Astiva Health (“Astiva” or the “Company”), a rapidly growing Medicare Advantage organization serving California’s diverse senior population, announced that it has [...]
YYZLabs Capital Expands Global Private Markets Focus from Singapore, Connecting Asian Investors and International Opportunities
02/09/2026
SINGAPORE, SINGAPORE, Sept. 02, 2026 (GLOBE NEWSWIRE) -- YYZLabs Capital is a Singapore-based boutique private markets firm with a global remit. Asia is a key foundation of the firm's business, while the firm also [...]
SciSparc: Subsidiary NeuroThera Labs Pursues FDA Orphan Drug Designation For Adult Tourette Syndrome Drug; Engages Government and Public Affairs Firm RK Strategies
02/09/2026
This strategic engagement is designed to strengthen NeuroThera’s U.S. market position, visibility among key U.S. federal stakeholders, reinforce the clinical and public ‑ health importance of advancing new treatment [...]
Equillium to Participate in Upcoming Investor Conferences
02/09/2026
LA JOLLA, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders, today announced that [...]
Artiva Biotherapeutics to Participate in Upcoming Investor Conferences in September
02/09/2026
SAN DIEGO, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV) (Artiva), a clinical-stage biotechnology company whose mission is to develop effective, safe and accessible cell therapies for [...]

Pages